AI-Powered Medical Imaging Triage

Work with radiology and emergency medicine leadership to define which findings trigger AI triage escalation. Establish clinical validation requirements and regulatory pathway (FDA clearance, local health authority approval). Start with conditions where delayed detection has the highest clinical impact: stroke on CT, pneumothorax on chest X-ray, and pulmonary embolism on CT angiography. Align priority selection with your hospital's case mix and volume data. In ASEAN markets, also consider TB screening given its prevalence in the region.

Evaluate FDA-cleared / CE-marked AI imaging solutions for your priority conditions. Run retrospective validation on your historical imaging data to confirm performance in your patient population. Document sensitivity, specificity, and processing time. Demand vendor transparency on the training data demographics; models trained predominantly on Western populations may underperform on Southeast Asian patient populations. Run your retrospective validation on at least 500 studies per condition, stratified by patient demographics. Require sensitivity above 90 percent for critical findings.

Connect AI models to your PACS (Picture Archiving and Communication System) for automatic study ingestion. Build worklist integration so AI priority scores reorder the radiologist queue. Implement notification system for critical findings. Use DICOM routing rules to send studies to the AI node immediately after acquisition, before they enter the standard worklist. Ensure the AI processing time adds no more than 60 seconds to the radiologist seeing the study. Build a fallback pathway so that if the AI node goes down, studies still reach the worklist normally.

Run AI triage in parallel with standard workflow — AI flags studies but radiologists process normally. Compare AI flags against final radiologist reports to validate real-world performance. Adjust sensitivity thresholds based on clinical feedback. Run the pilot for a minimum of 6 weeks to capture enough positive cases for statistical significance. Have radiologists document their agreement or disagreement with each AI flag in a structured form. Calculate sensitivity and specificity using the final radiology report as ground truth, not the AI output.

Activate AI-driven worklist prioritisation. Monitor turnaround times, false positive/negative rates, and radiologist satisfaction. Track patient outcomes for AI-flagged vs. non-flagged studies. Report to clinical governance and quality committees. Establish a clinical governance review cadence: weekly for the first month, then monthly. Track two metrics religiously: time-to-report for AI-flagged critical findings and the false negative rate. Any false negative on a critical condition should trigger an immediate root cause review with the vendor.